MiR-134, Mediated by IRF1, Suppresses Tumorigenesis and Progression by Targeting VEGFA and MYCN in Osteosarcoma
Source: Anti-Cancer Agents in Medicinal Chemistry - Category: Cancer & Oncology Authors: Ma, Zhuo Li, Kai Chen, Peng Pan, Qizheng Li, Xuyang Zhao, Guoqing Tags: Research article Source Type: research